#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15298	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2120	715.1	0	.	n	.	0	C741T	SNP	741	741	C	989	989	T	937	T	895	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15298	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2120	715.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1698	1698	T	815	T	763	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15298	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2120	715.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1432	1432	C	879	C	843	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15298	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2120	715.1	0	HET	.	.	.	C207T	.	207	207	C	455	455	C	845	C,T	600,186	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27636	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3576	769.9	0	.	n	.	0	G1337A	SNP	1337	1337	G	1710	1710	A	948	A	897	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27636	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3576	769.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2344	2344	C	851	C	796	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27636	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3576	769.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2418	2418	A	842	A	812	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27636	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3576	769.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2970	2970	C	802	C	768	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2310	folP	855	855	100.0	folP.l15.c30.ctg.1	1646	139.9	1	SNP	p	R229S	1	.	.	685	687	AGC	1099	1101	AGC	241;242;242	A,G;G;C,T	220,1;219;219,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6166	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	179.5	1	SNP	p	S91F	1	.	.	271	273	TTC	627	629	TTC	236;237;234	T;T;C	224;224;220	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6166	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	179.5	1	SNP	p	G95N	0	.	.	283	285	GGC	639	641	GGC	239;235;236	G,T;G;C	225,1;221;221	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6166	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3425	179.5	1	SNP	p	D95G	1	.	.	283	285	GGC	639	641	GGC	239;235;236	G,T;G;C	225,1;221;221	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1818	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1323	136.5	1	SNP	p	G45D	0	.	.	133	135	GGC	472	474	GGC	221;224;222	G,T;G;C	207,1;209;204	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	938	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1151	81.0	0	.	n	.	0	A197.	DEL	197	197	A	663	663	A	204	A	193	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1604	1606	GTC	196;195;194	G;T;C	180;182;180	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	1	SNP	p	D86N	0	.	.	256	258	GAC	710	712	GAC	209;209;212	G,C;A,C;C	199,1;198,1;204	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	1	SNP	p	R87I	0	.	.	259	261	CGT	713	715	CGT	212;212;211	C;G;T	204;203;200	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	1	SNP	p	S87R	1	.	.	259	261	CGT	713	715	CGT	212;212;211	C;G;T	204;203;200	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	1	SNP	p	R87W	0	.	.	259	261	CGT	713	715	CGT	212;212;211	C;G;T	204;203;200	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	5444	parC	2304	2304	99.87	parC.l6.c30.ctg.1	3091	175.3	1	SNP	p	S88P	0	.	.	262	264	TCC	716	718	TCC	210;208;208	T;C;C	202;201;201	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4754	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2602	181.7	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1260	1262	TGC	230;230;234	T,C;G;C	215,1;216;219	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4754	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2602	181.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1470	1472	GGC	232;234;235	G;G;C	221;221;224	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1292	1294	GCA	233;232;233	G;C;A	220;218;222	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1295	1297	ATC	233;238;239	A;T;C,T	218;226;224,1	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1307	1309	GTG	243;241;241	G;T;G	234;229;229	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1307	1309	GTG	243;241;241	G;T;G	234;229;229	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1811	1813	ACC	211;209;212	A;C;C	188;197;197	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1865	1867	GCG	198;199;199	G;C,T;G	177;160,1;166	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1865	1867	GCG	198;199;199	G;C,T;G	177;160,1;166	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1988	1990	GGC	173;175;173	G;G;C	166;169;169	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1997	1999	GGC	177;175;176	G;G;C	170;169;167	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	4294	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2548	168.0	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2015	2017	TCG	173;177;175	T,G;C,G;G	100,9;140,1;143	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5980	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3036	196.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1582	1584	CCG	232;232;234	C;C;G	214;216;217	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2532	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1940	129.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	185	C,A	172,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	434	436	GAA	258;258;259	G;A;A	246;245;245	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	722	724	GAT	235;236;239	G;A;T	221;221;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	845	847	TCA	261;261;263	T;C;A	245;245;248	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	974	976	GTC	232;236;235	G;T;C	223;225;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	0	.	p	.	0	E328V	NONSYN	982	984	GAA	1304	1306	GTA	214;214;216	G;T;A	203;204;205	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	1	SNP	p	G120K	1	.	.	358	360	AAG	680	682	AAG	244;246;253	A;A;G	230;231;236	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	1	SNP	p	D121N	0	.	.	361	363	GAC	683	685	GAC	251;254;251	G;A;C	234;239;236	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2922	porB1b	1047	1047	99.33	porB1b.l15.c17.ctg.1	1509	192.4	1	SNP	p	A121D	1	.	.	361	363	GAC	683	685	GAC	251;254;251	G;A;C	234;239;236	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10956	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4849	225.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2026	2028	AAT	224;222;223	A;A;T	218;217;216	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1266	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1040	120.5	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	261;261;256	A;T;G	253;254;248	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
